Literature DB >> 12849789

Vaccines for the prevention of neglected diseases--dengue fever.

Tikki Pang1.   

Abstract

Dengue and dengue hemorrhagic fever have spread to all tropical areas of the developing world, but still remain largely neglected diseases. Several promising vaccine candidates in the form of live attenuated and chimeric vaccines have been developed and are currently in human clinical trials. However, significant practical, logistic, and scientific challenges remain before these vaccines can widely and safely be applied to vulnerable populations. Vector control, community education and public health measures must be pursued in parallel with vaccine development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12849789     DOI: 10.1016/s0958-1669(03)00061-2

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  4 in total

1.  Indoor-breeding of Aedes albopictus in northern peninsular Malaysia and its potential epidemiological implications.

Authors:  Hamady Dieng; Rahman G M Saifur; Ahmad Abu Hassan; M R Che Salmah; Michael Boots; Tomomitsu Satho; Zairi Jaal; Sazaly AbuBakar
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

2.  Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus.

Authors:  See Ven Lim; Mohd Basyaruddin A Rahman; Bimo A Tejo
Journal:  BMC Bioinformatics       Date:  2011-11-30       Impact factor: 3.169

3.  Dengue emergence and adaptation to peridomestic mosquitoes.

Authors:  Abelardo C Moncayo; Zoraida Fernandez; Diana Ortiz; Mawlouth Diallo; Amadou Sall; Sammie Hartman; C Todd Davis; Lark Coffey; Christian C Mathiot; Robert B Tesh; Scott C Weaver
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

4.  The mannose receptor mediates dengue virus infection of macrophages.

Authors:  Joanna L Miller; Barend J M de Wet; Barend J M deWet; Luisa Martinez-Pomares; Catherine M Radcliffe; Raymond A Dwek; Pauline M Rudd; Siamon Gordon
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.